Chromosome 1p loss:: A favorable prognostic factor in low-grade gliomas

被引:68
作者
Kujas, M
Lejeune, J
Benouaich-Amiel, A
Crinière, E
Laigle-Donadey, F
Marie, Y
Mokhtari, K
Polivka, M
Bernier, M
Chretien, F
Couvelard, A
Capelle, L
Duffau, H
Cornu, P
Broët, P
Thillet, J
Carpentier, AF
Sanson, M
Hoang-Xuan, K
Delattre, JY
机构
[1] INSERM, U711, F-75654 Paris, France
[2] Univ Paris 06, F-75252 Paris, France
[3] Grp Hosp Pitie Salpetriere, APHP, Lab Neuropathol R Escourolle, Paris, France
[4] Grp Hosp Pitie Salpetriere, Serv Neurol Mazarin, F-75634 Paris, France
[5] Hop Lariboisiere, Serv Anatomopathol, F-75475 Paris, France
[6] Hop Foch, Serv Anatomopathol, Suresnes, France
[7] Hop Henri Mondor, Serv Anatomopathol, F-94010 Creteil, France
[8] Hop Beaujon, Serv Anatomopathol, Clichy, France
[9] Grp Hosp Pitie Salpetriere, Serv Neurochirurg, F-75634 Paris, France
[10] Hop Paul Brousse, INSERM, U472, Villejuif, France
关键词
D O I
10.1002/ana.20543
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Search for loss of heterozygosity on chromosomes 1p, 9p, 10q, and 19q, epidermal growth factor receptor (EGFR) gene amplification, and p53 expression was performed in a series of 131 low-grade gliomas. The profile of molecular changes, clinical findings, and histology were subsequently correlated with the course of the disease, mainly progression-free survival. When these parameters were considered as candidate variables in a multivariate analysis, only loss of heterozygosity on chromosome 1p was associated with increased progression-free survival (hazard ratio, 0.521), indicating a major favorable prognostic role of this genetic alteration in low-grade gliomas.
引用
收藏
页码:322 / 326
页数:5
相关论文
共 14 条
  • [1] Glioblastomas with an oligodendroglial component: A pathological and molecular study
    He, J
    Mokhtari, K
    Sanson, M
    Marie, Y
    Kujas, M
    Huguet, S
    Leuraud, P
    Capelle, L
    Delattre, JY
    Poirier, J
    Hoang-Xuan, K
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2001, 60 (09) : 863 - 871
  • [2] Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions
    Hoang-Xuan, K
    Capelle, L
    Kujas, M
    Taillibert, S
    Duffau, H
    Lejeune, J
    Polivka, M
    Crinière, E
    Marie, Y
    Mokhtari, K
    Carpentier, AF
    Laigle, F
    Simon, JM
    Cornu, P
    Broët, P
    Sanson, M
    Delattre, JY
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (15) : 3133 - 3138
  • [3] Subtyping of oligo-astrocytic tumours by comparative genomic hybridization
    Jeuken, JWM
    Sprenger, SHE
    Boerman, RH
    von Deimling, A
    Teepen, HLJM
    van Overbeeke, JJ
    Wesseling, P
    [J]. JOURNAL OF PATHOLOGY, 2001, 194 (01) : 81 - 87
  • [4] A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European organization for research and treatment of cancer (EORTC) study 22844
    Karim, ABMF
    Maat, B
    Hatlevoll, R
    Menten, J
    Rutten, EHJM
    Thomas, DGT
    Mascarenhas, F
    Horiot, JC
    Parvinen, LM
    vanReijn, M
    Hamers, HP
    Gaspar, L
    Noordman, E
    Pierart, M
    vanGlabbeke, M
    vanAlphen, AM
    Jager, JJ
    Fabrini, MG
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 36 (03): : 549 - 556
  • [5] Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer study 22845 with the Medical Research Council study BRO4: An interim analysis
    Karim, ABMF
    Afra, D
    Cornu, P
    Bleehan, N
    Schraub, S
    De Witte, O
    Darcel, F
    Stenning, S
    Pierart, M
    Van Glabbeke, M
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 52 (02): : 316 - 324
  • [6] Molecular genetic evidence for subtypes of oligoastrocytomas
    Maintz, D
    Fiedler, K
    Koopmann, J
    Rollbrocker, B
    Nechev, S
    Lenartz, D
    Stangl, AP
    Louis, DN
    Schramm, J
    Wiestler, OD
    vonDeimling, A
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1997, 56 (10) : 1098 - 1104
  • [7] Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets
    Mueller, W
    Hartmann, C
    Hoffmann, A
    Lanksch, W
    Kiwit, J
    Tonn, J
    Veelken, J
    Schramm, J
    Weller, M
    Wiestler, OD
    Louis, DN
    von Deimling, A
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2002, 161 (01) : 313 - 319
  • [8] Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas
    Okamoto, Y
    Di Patre, PL
    Burkhard, C
    Horstmann, S
    Jourde, B
    Fahey, M
    Schüler, D
    Probst-Hensch, NM
    Yasargil, MG
    Yonekawa, Y
    Lütolf, UM
    Kleihues, P
    Ohgaki, H
    [J]. ACTA NEUROPATHOLOGICA, 2004, 108 (01) : 49 - 56
  • [9] Prognostic factors for survival in adult patients with cerebral low-grade glioma
    Pignatti, F
    van den Bent, M
    Curran, D
    Debruyne, C
    Sylvester, R
    Therasse, P
    Afra, D
    Cornu, P
    Bolla, M
    Vecht, C
    Karim, ABMF
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (08) : 2076 - 2084
  • [10] REIFENBERGER J, 1994, AM J PATHOL, V145, P1175